Online Livestream
3rd Virtual
3rd VirtualClinical Trials
What To Expect

The 3rd Virtual Clinical Trials Conference is the industry’s recognized leading event for overcoming technology barriers, accelerating the adoption of digital trials, and building team capabilities around these now-essential methods. Our speaking faculty of over 25 industry thought-leaders guide you through the necessary changes in your clinical infrastructure, while emphasizing how to always put patients first. No other event offers so many all-new insights on comparing methods for virtual studies, rising to the challenges of incorporating AI into remote trials, and reorienting virtual trial design around the patient perspective. Join us to revolutionize your clinical research pipeline – and turn today’s emergency into tomorrow’s opportunity.

Event Sponsors
Conference
New Topics
Featured Speakers
Alicia Staley
Senior Director, Patient Engagement
Medidata, a Dassault Systèmes company
Alka Shaunik
Global Therapy Area Head, Cardiovascular & Metabolism, Medical Affairs
CSL BEHRING
Bibhudatta Mishra
Senior Clinical Trial Scientist
JOHNS HOPKINS MEDICINE
Claus Torp Jensen
Chief Digital Officer and Chief Technology Officer
MEMORIAL SLOAN KETTERING CANCER CENTER
Craig Lipset
Founder
CLINICAL INNOVATION PARTNERS
Daniella Hensley
Director, Global Clinical Operations
JANSSEN
Dimitri Talantov
Sr. Director Medical Affairs Clinical Trial Innovation
JANSSEN
Elizabeth Stoner
Senior Clinical Advisor
ALLOVIR
Emily Kunka
Digital Transformation Project Lead
UCB
Hassan Kadhim
Director, Global Head of Clinical Trial Business Capabilities and Clinical Innovation
BRISTOL MYERS SQUIBB
Jen Horonjeff
Patient Advocate, Founder and CEO
SAVVY COOPERTIVE
John Reites
CEO
THREAD
Lesley Schofield
Director of Clinical Trial Operations, U S Medical Affairs
NOVARTIS
Lorena Kuri
Head, Diversity Strategy
BRISTOL-MYERS SQUIBB
Maimah Karmo
Patient Advocate, CEO
TIGERLILY FOUNDATION
Michael Song
Senior Manager, Head of Device Functionality, Safety, and Digital Connectivity
ASTRAZENECA
Michael Tucker
Senior Product Solutions Specialist
Medidata, a Dassault Systèmes company
Michelle Luo
Head of Global Evidence & Outcomes
TAKEDA
Mike Collins
Senior VP, Clinical Operations & Data Sciences
AKEBIA THERAPEUTICS
Nancy Sacco
VP, Clinical Development
MEITHEAL SPECIALTY PHARMA
Nina Renner-Thomas
Clinical Project Lead, Manager, Clinical Operations
JUUL Labs
Safwan Kezbor
Medical Director, Clinical Development
SHIONOGI
Shameer Khader
Senior Director, Data Science, Digital Health, and Bioinformatics
ASTRAZENECA
Sharon Terry
Patient Advocate, Founder and CEO
Genetic Alliance
T.J. Sharpe
Patient Advocate
TJSharpe.com
Vanessa Gertsen
Head, Recruitment Strategy, Clinical Trial Engagement & Enrollment
BRISTOL-MYERS SQUIBB
Wendy Wu
Director, Clinical Development
JAZZ PHARMACEUTICALS
Event Schedule
  • Communicate the level of validation needed in order to make claims on data
  • Upgrade due diligence around the technologies that clinical trial teams must have in place
  • Bridge gaps in levels of inherent knowledge
  • Explore select differences in launching hybrid decentralized studies in Europe, Asia Pacific and South America
  • Discuss flexible approaches for eConsent, telehealth, eCOA sensors and home health
  • Review lessons learned to date with global DCT expansion
  • Reduce the need for site visits through at-home monitoring
  • Gather and reliably archive patient feedback on drug formulation and delivery
  • Turn a challenging time into new opportunity, with trial structures that more easily fit into patients’ routines
  • Explore the potential of remote models
  • Recognize and adapt to burdens and complexities of multiple stakeholders
  • Evaluate vendor capabilities to move beyond virtual sites and take on both CRO and site capabilities
  • Understand the regulatory guidance available and consider the implications to the regulatory strategy for products that use these novel approaches in clinical trials.
  • Utilize novel approaches to clinical trials within a context of COVID-19
  • Explore the US FDA guidance documents published related to COVID-19 pandemic and provide regulatory insights as to moving forward in our ‘new normal’ of clinical trial development.
  • Leverage a single destination for all trial virtualization technologies
  • Incorporate and harness the patient voice in the design of a decentralized trial
  • Improve patient access to clinical trials using registries
  • Review how the industry combines conventional strategies with virtual trials
  • Restructure internal processes as needed for implementation
  • Investigate the most cost-effective applications and outcomes
  • Analyze how digital health tools can move trials forward
  • Ensure the data integrity and subjects' safety monitoring in the virtual clinical trials implementation
  • Explore areas requiring change in order to drive sustaining adoption in the organization
  • Discuss specific examples spanning processes, vendor selection, training and protocol authoring
  • Share experiences managing organizational change to recognize pitfalls and drivers of success
  • Hear the insights gained from designing and implementing transformational solutions for the new era that will propel the future of drug development
  • Discover how to use a lens of business-to-consumer product evolution
  • Examine actual client needs from this past year as case studies showing how we can shape an “Amazon experience”
  • Identify and increase focus on patients and evolving customer needs to deliver solutions that are relevant and long-lasting
  • Outline how the proper technology choices can help or hinder you
  • Compare and contrast technical platform options
  • Focus on the clinical trial without commercial consideration
  • Evaluate the benefits of virtual meetings in terms of cost and convenience
  • Compare different methods for gathering information through “breakouts
  • Review new outreach options for CRAs and training
  • Clarify in advance the needs for tech support
  • Explore the most up-to-date options for large-scale data analysis for virtual trials
  • Address common mistakes and misperceptions
  • Clarify what is realistically possible for digital health and bioinformatics in a remote setting
  • Determine the most important indicators of site quality
  • Plan creative collaboration and flexible strategies
  • Find the fastest techniques for site quality maximization
  • Recognize how behavior influences team results
Register Now

This window is secured by 256 bit encryption on a PCI compliant network. Click here to view this window in its own page.

Subscribe to Conference Updates
Join our e-newsletter list to follow closely all news.
Event Partners
15
Speakers
21
Days
251
Participants
125
Workshops
90
Venue
Contact Us